200,000+ products from a single source!

sales@angenechem.com

Home > Indole Alkaloid Synthesis Facilitated by Photoredox Catalytic Radical Cascade Reactions

Indole Alkaloid Synthesis Facilitated by Photoredox Catalytic Radical Cascade Reactions


Xiao-Yu Liu  and Yong Qin

 

 

1.INTRODUCTION
Indole alkaloids belong to one of the largest families of secondary metabolites created by nature.1 As a unique category of these molecules, the monoterpene indole alkaloids biogenetically originate from tryptamine and secologanin (Figure 1).2 Condensation of these two fragments via an enzymatic Pictet−Spengler reaction affords strictosidine; diversification of the latter common intermediate results in over 40 structural types and more than 3000 members of monoterpene indole alkaloids.1 Of particular note, many of these compounds exhibit a wide range of bioactivities, and molecules such as reserpine (antihypertensive), vincamine (nootropic), quinine (antimalaria), and vinblastine/vincristine (antitumor) have been used as important drugs.

 

Due to their significant biological profiles and intricate structures, various monoterpene indole alkaloids have long challenged synthetic chemists. Such synthetic campaigns could be traced back to as early as the 1950s, when Woodward and co-workers first conquered strychnine4 and reserpine.5 Since then, the structural diversity and complexity of monoterpene indole alkaloids have made them important testing grounds for synthetic   methodologies   and   tactics.6   Traditionally, many elegant approaches were documented but were only suitable for the synthesis of individual molecules or small groups of molecules from this natural product family. However, efficient access to large collections of complex indole alkaloids is always desirable and would call for a breakthrough in developing innovative synthetic methods and strategies.

 

Visible-light-mediated photoredox chemistry has been an active research field in the most recent decade and offers chemists new opportunities to form chemical bonds.7 Never- theless, these single electron transfer (SET) processes have only begun to benefit natural product total synthesis,8,9 and they were mostly employed to realize single transformations. Design of visible light photoinduced radical cascade reactions to facilitate multiple bond-forming events in one pot would allow chemists to assemble the cores of natural products as well as to achieve their total synthesis in highly efficient fashion.


Stemming from a long-standing interest in the synthesis of intriguing indole alkaloids,10,11 our group recently developed a new photoredox catalytic radical cascade strategy that led to the asymmetric total synthesis of a collection of monoterpene indole alkaloids.12−16 As illustrated in Scheme 1, treating the sulfonamide substrate A with base and photocatalyst under the irradiation of blue light-emitting diodes (LEDs) generated a key nitrogen-centered radical B, which could be subsequently involved in further bond-forming events. Specifically, we designed three types of radical cascade pathways [intra-/ intramolecular, intra-/intermolecular, and intra-/inter-/intra- molecular] and realized facile construction of the aspidosper- ma (type I, via C), tetrahydrocarbolinone (type II, via D), and corynanthe (type III, via E) core structures. While some of the obtained compounds already possessed the frameworks of indole alkaloids, the versatile functionalities in these cores could be manipulated to access more alkaloid types. As a result, harnessing the three types of photocatalytic radical cascades as key reactions allowed the asymmetric total synthesis of 42 monoterpene indole alkaloids belonging to 7 structural types.12−16 This Account summarizes the radical cascade methodologies developed in our laboratory and their applications in natural product total synthesis.

 

2.TYPE I RADICAL CASCADE AND ITS APPLICATIONS IN TOTAL SYNTHESIS
2.1.Development of the Type I Radical Cascade Reaction
Bearing in mind the idea of developing a radical cascade approach to indole-alkaloid skeletons, we initiated our studies with the preparation of chiral substrate 4 (Scheme 2) from tert- butyl methyl malonate (1) and o-nitrocinnamic aldehyde (2). The organocatalytic asymmetric Michael addition of commer- cially available 1 to 2 followed by decarboxylation yielded chiral aldehyde ester 3 (96% ee),17 which was readily conducted on a 500 g scale in our laboratory. Compound 3 was then converted  to 4 in three steps. By subjecting sulfonamide 4 to various non-photoredox conditions, we observed the cyclization product (tetrahydroquinoline 5) or oxidation product (pyridinone 6) or no reaction. Generation of tetrahydroquinoline 5 was, not surprisingly, the result of a C− N bond formation between the aniline nitrogen and the electron-deficient α-carbon of the enamide functionality. To reach the desired indoline product, a C−N bond formation at the β-position of the enamide was required. Classical methods for the generation of nitrogen-centered radicals18 from N− heteroatom bonds or directly from N−H bonds under harsh oxidative conditions were neither economic nor environ- mentally benign, which also proved to be unsuitable for our substrate. After much experimentation, we were delighted to isolate the tetracyclic product 7a (41% yield) along with tricycles 8 (6% yield) and 9 (35% yield) in the reaction of 4 with Ir(dtbbpy)(ppy)2PF6 and Et3N under the irradiation of blue LEDs.


Obviously, not only an unusual reactivity between two nucleophilic amine and enamine groups (in 4) but also an impressive radical cascade reaction (product 7a) was achieved in the aforementioned photocatalytic transformation. With the initial results, we next screened the reaction conditions and found that the radical cascade of 4 proceeded smoothly to produce 7a in 70% yield (>50:1 dr) using Ir(dtbbpy)- (ppy)2PF6 (0.5 mol %; dtbbpy = 4,4′-bis(di-t-butyl)-2,2′- bipyridine; ppy = 2-phenylpyridine) and KHCO3 in degassed THF with irradiation of 5 W blue LEDs. In addition to 4, a series of substrates were designed and synthesized to examine the generality of this intra-/intramolecular radical cascade reaction. As depicted in Figure 2,12 substrates possessing either electron-rich or electron-deficient double/triple bonds teth- ered to the enamide nitrogen atom were suitable for the cascade reaction, furnishing the corresponding products (e.g., selected examples 7b−e) with fused pyrrolidine or piperidine rings in moderate to high yields and high to excellent dr values. Exceptionally, the adduct 7f with a more flexible azepane unit was generated with a lower dr value (2.5:1). Of note, this cascade reaction proved to be robust and worked without loss of yield and diastereoselectivity in aqueous THF (product 7a). A proposed catalytic cycle for the  photoredox  radical  cascade reaction is shown in Scheme 3A. Initially, deprotona- tion of the N−H bond in 10 took place in the presence of base to generate anion I. The photoexcited IrIII complex then oxidized I (via SET) and produced nitrogen-centered radical II, triggering subsequent cascade cyclization to yield carbon radical III. After SET reduction of radical III with the reductive state IrII complex, the resultant anion IV could be converted into product 7 via protonation. Regeneration of the ground-state IrIII photocatalyst completed the catalytic cycle.

 

Concerning the observed stereoselectivity of the radical cascade, formation of a cis relationship between H2 and H7 via transition state TS-I was realized in a substrate-controlled fashion (Scheme 3B).12 The resulting amide nitrogen- associated carbon radical might adopt two transition states, TS-IIa and TS-IIb, which acted as controllable switches for the subsequent reactions. The N-atom in TS-IIa had no contribution to enhancing the nucleophilicity of the adjacent carbon radical due to donation of the nitrogen lone pair electrons to the carbonyl moiety in the characteristic amide functionality. On the other hand, unfavorable steric repulsion between the Ts-protected indoline group and the radical acceptor in TS-IIa also inhibited occurrence of the ensuing reaction. By contrast, the key two-center, three-electron interaction in TS-IIb greatly contributed to enhancing the radical stability, nucleophilicity, and selectivity.19 First, because of the greater stability, the sufficient lifetime of the carbon radical enabled subsequent bond formations especially in intermolecular manners (type II and III cascades). Second, twisting of the amide bond in TS-IIb restored the electron- donating ability of the N-atom to the carbon radical, thus increasing the radical nucleophilicity. Furthermore, attack of the carbon radical to the intramolecular acceptors (or intermolecular ones in type II and III cascades) exclusively from the bottom face of the piperidinone ring led to complete stereocontrol at C3.

 

2.2.Total Synthesis of the Eburnane Alkaloids
Inspired by the development of an intra-/intramolecular radical cascade for preparing indole-alkaloid-like  skeletons, we sought to investigate its applications in natural product total synthesis. The eburnane indole alkaloids (Figure 3) are a group of structurally diverse molecules featuring a common pentacyclic core (e.g., 11−13) and an all-carbon quaternary center at C20.20,21 Functionalizations at the terminal C18 as well as further cyclizations may result in more variants of these natural products (e.g., 14−17). In this context, the C18 unfunctionalized eburnane alkaloids were envisaged to be synthesized from 18a (R = H), while various C18 function- alized counterparts could be derived from 18b (R = OPG). In turn, the versatile tetracyclic intermediate 18a,b with a crucial C20 quaternary stereogenic center would be accessible by the photocatalytic type I radical cascade of precursor 19a,b.

 

According to the synthetic plan, preparation of the C18 unfunctionalized eburnane alkaloids was examined using sulfonamide 20 as a starting material (Scheme 4).12 To evaluate the potential applications of a new synthetic methodology, especially in natural product total synthesis, an important criterion is whether it could be scaled up without loss of efficacy. Gratifyingly, the designed radical cascade reaction of 20 was easily performed on a decagram scale under photocatalytic conditions,12 where the solvent MeCN was found to be superior to THF, giving the bis-cyclization products 21a and 21b (81% overall yield, 2:3 dr). As most C18 unfunctionalized eburnane alkaloids possess a β-Et substituent at C20, the corresponding intermediate 21b with a β-Et group was used for further manipulations. On one hand, three steps of functional group transformations converted 21b into acetal. Reduction of the amide group in 22 to the corresponding amine followed by treatment with TFA afforded (+)-eburna- menine (23) in 80% overall yield. Subsequent hydration of the C16−C17 double bond delivered (−)-eburnamine (11) and (+)-isoeburnamine (12); oxidation of the resultant hydroxyl group with pyridinium dichromate (PDC) gave (+)-eburna- monine (24). The intermediate 22 was also used for the synthesis of (−)-vallesamidine (26). Establishing the remain- ing five-membered carbocycle in 26 relied on a SmI2-mediated reductive cyclization of the aldehyde to the C2 of indole. On the other hand, subjecting 21b to a four-step sequence produced amino alcohol 27. The latter underwent oxidation/ cyclization/oxidation to generate lactam 28, which was finally converted into (−)-vincamine (13) according to a literature method.

 

Employing precursor 29 with a C18-OBn group for the radical cascade reaction under the standard photoredox conditions smoothly furnished the tetracyclic product 30 as a pair of inseparable diastereomers (Scheme 4).14 Both isomers were used for accessing eburnane indole alkaloids with C18 functionalities. Specifically, the diastereomeric mixture of 30 was converted to separable 31a and 31b by three steps. Treatment of the minor 31a with HCl/MeOH at reflux forged a new lactam ring with simultaneous removal of the benzyl radical acceptors, respectively. Again, the stereochemical outcomes of the newly formed stereocenters (C2 and C3) were excellently controlled in all of the products.

 

Total Synthesis of the Akuammiline Alkaloids (−)-Strictamine and (−)-Rhazinoline
Strictamine and its associated akuammiline alkaloids (43−45, Figure 5) are structurally unique natural products possessing a group,  which was followed by Dess−Martin periodinane (DMP) oxidation of the resultant primary alcohol, leading to aldehyde 32. A SmI2-mediated radical cyclization of 32 with subsequent Barton deoxygenation generated (−)-strempelio- pine (15). Meanwhile, starting from 31b, formation of a hemiaminal with ensuing deprotection of the benzyl group yielded (−)-eburnaminol (14); the latter was treated with HCl to give (+)-larutenine (33). On the other hand, first removal of the benzyl group in 31b, followed by oxidation and cyclization in the presence of Bz2O2, furnished tetrahydropyran 34. Exposure of 34 to di-isobutyl aluminum hydride (DIBAL-H) at 0 °C completed the synthesis of (−)-terengganensine B (16). Moreover, the radical cascade product (30) underwent a five-step transformation to provide access to the diallyl product.  Ring-closing  metathesis  (RCM)  of  35  with  Grubbs’ II catalyst delivered 36 (82% yield); the latter was further converted to (−)-terengganensine A (17) based on the method developed by Zhu and colleagues.
 

Over 100,000 products now available from Angene:

CAS No. 113588-11-7

1(2H)-Pyrimidinepropanamine, N-heptadecenyl- (9CI)

Catalog No.:AG000930 MDL No.:

MF:C24H45N3 MW:375.6342

CAS No. 113588-12-8

Butane, tetrakis(hydroxyphenyl)- (9CI)

Catalog No.:AG00092Z MDL No.:

MF:C28H26O4 MW:426.5036

CAS No. 113588-14-0

Benzene, tetrabromobis(2,3,4,5,6-pentabromophenoxy)-

Catalog No.:AG00092Y MDL No.:

MF:C18Br14O2 MW:1366.8474

CAS No. 113588-16-2

Hydroperoxide, 1-methyl-1-(methylphenyl)propyl (9CI)

Catalog No.:AG00092X MDL No.:

MF:C11H16O2 MW:180.2435

CAS No. 113592-13-5

Propanoic acid, 3-[(1-aminoethyl)hydroxyphosphinyl]-

Catalog No.:AG00093O MDL No.:

MF:C5H12NO4P MW:181.1268

CAS No. 113592-29-3

Nonanoic acid, 2-[[(1-aminoethyl)hydroxyphosphinyl]methyl]-

Catalog No.:AG00093N MDL No.:

MF:C12H26NO4P MW:279.3129

CAS No. 113592-40-8

Butanedioic acid, 2-methylene-, 4-(1,1-dimethylethyl) 1-methyl ester

Catalog No.:AG00093M MDL No.:

MF:C10H16O4 MW:200.2316

CAS No. 113592-82-8

2,4-Octadienoic acid, 8-hydroxy-6-methyl-, (E,E)- (9CI)

Catalog No.:AG00093L MDL No.:

MF:C9H14O3 MW:170.2057

CAS No. 113592-99-7

Bicyclo[4.2.0]octa-1,3,5,7-tetraene, 3-(chloromethyl)-

Catalog No.:AG00093K MDL No.:MFCD19234015

MF:C9H7Cl MW:150.6049

CAS No. 113593-00-3

Carbamic acid, (3-chlorophenyl)-, 1-methylheptyl ester (9CI)

Catalog No.:AG00093J MDL No.:

MF:C15H22ClNO2 MW:283.7937

CAS No. 113593-13-8

Cerium, dichloro[(trimethylsilyl)methyl]-

Catalog No.:AG00093I MDL No.:

MF:C4H11CeCl2Si MW:298.2376

CAS No. 113593-14-9

Silane, trimethyl(2-methyleneundecyl)-

Catalog No.:AG00093H MDL No.:

MF:C15H32Si MW:240.5001

CAS No. 1135935-39-5

1H-Indole-3-carboxylic acid, 5-(difluoromethoxy)-

Catalog No.:AG000934 MDL No.:

MF:C10H7F2NO3 MW:227.1643

CAS No. 1135935-41-9

1H-Indole-3-carboxylic acid, 6-(difluoromethoxy)-

Catalog No.:AG000933 MDL No.:

MF:C10H7F2NO3 MW:227.1643

CAS No. 1135936-11-6

1H-Indazole-3-carbonyl chloride, 5-fluoro-

Catalog No.:AG000932 MDL No.:

MF:C8H4ClFN2O MW:198.5816

CAS No. 113594-68-6

1-Piperazineacetic acid, 4-[(3,4,5-trimethoxyphenyl)methyl]-, 4-methoxyphenyl ester, (2E)-2-butenedioate (1:2) (9CI)

Catalog No.:AG00093G MDL No.:

MF:C31H38N2O14 MW:662.6384

CAS No. 113596-04-6

Acetamide, N-(3-amino-4-fluorophenyl)-

Catalog No.:AG00093F MDL No.:MFCD07368688

MF:C8H9FN2O MW:168.1683

CAS No. 113597-22-1

2-Nonenoic acid, 6-hydroxy-2-methyl-8-oxo-, (E)- (9CI)

Catalog No.:AG00093E MDL No.:

MF:C10H16O4 MW:200.2316

CAS No. 113597-40-3

2-Propenoic acid, 2-nitro-3-[2-(tetrahydro-1,3-dimethyl-5-nitroso-2,6-dioxo-4(1H)-pyrimidinylidene)hydrazinyl]-, ethyl ester

Catalog No.:AG00093D MDL No.:

MF:C11H14N6O7 MW:342.2649

CAS No. 113597-43-6

2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-, 2,4,6-trihydrazone

Catalog No.:AG00093C MDL No.:

MF:C6H14N8 MW:198.2290

CAS No. 113597-46-9

Pyrrolo[2,3-e]benzimidazole, 1,8-dihydro-2,6-dimethyl-7-phenyl-

Catalog No.:AG00093B MDL No.:

MF:C17H15N3 MW:261.3211

CAS No. 113597-79-8

Propanoic acid, 2-hydroxy-, 4-methoxyphenyl ester

Catalog No.:AG00093A MDL No.:

MF:C10H12O4 MW:196.1999

CAS No. 113598-55-3

1-Propanone, 2,2-dimethyl-1-(4-methylphenyl)-3-phenyl-

Catalog No.:AG000939 MDL No.:

MF:C18H20O MW:252.3508

CAS No. 113598-97-3

1-Pyreneoctanamine, hydrochloride (1:1)

Catalog No.:AG000938 MDL No.:

MF:C24H28ClN MW:365.9388

CAS No. 113599-15-8

1-Undecanone, 11-amino-1-(4-bromo-1-naphthalenyl)-

Catalog No.:AG000937 MDL No.:

MF:C21H28BrNO MW:390.3571

CAS No. 113599-17-0

α-D-Ribofuranose, 1,5-bis(dihydrogen phosphate), tetrasodium salt (9CI)

Catalog No.:AG000936 MDL No.:

MF: MW:

CAS No. 113599-55-6

2,4(3H,5H)-Furandione, 3-(1-methylethyl)-

Catalog No.:AG000935 MDL No.:

MF:C7H10O3 MW:142.1525

CAS No. 1135992-31-2

Boronic acid, B-[2-chloro-4-(methoxymethoxy)phenyl]-

Catalog No.:AG000931 MDL No.:MFCD22056737

MF:C8H10BClO4 MW:216.4266

CAS No. 1136-11-4

Methanone, (3,5-dimethyl-1H-pyrazol-4-yl)phenyl-

Catalog No.:AG00093P MDL No.:

MF:C12H12N2O MW:200.2365

CAS No. 1136-21-6

Glucopyranose,2,3,4-tri-O-methyl-

Catalog No.:AG00094D MDL No.:

MF:C9H18O6 MW:222.2356

CAS No. 1136-23-8

2H-Pyran-2,6(3H)-dione, dihydro-3-(2-methylphenyl)-

Catalog No.:AG00094C MDL No.:

MF:C12H12O3 MW:204.2219

CAS No. 1136-45-4

4-Isoxazolecarboxylic acid, 5-methyl-3-phenyl-

Catalog No.:AG00094B MDL No.:MFCD00003153

MF:C11H9NO3 MW:203.1941

CAS No. 1136-52-3

4H-1,3-Dioxino[4,5-c]pyridine-5-methanol, 2,2,8-trimethyl-

Catalog No.:AG00094A MDL No.:MFCD00233509

MF:C11H15NO3 MW:209.2417

CAS No. 1136-56-7

Methanol, 1-(9H-fluoren-9-ylidene)-

Catalog No.:AG000949 MDL No.:

MF:C14H10O MW:194.2286

CAS No. 1136-60-3

1H-Pyrazole-4-methanol, 5-chloro-3-methyl-1-phenyl-

Catalog No.:AG000948 MDL No.:MFCD00514523

MF:C11H11ClN2O MW:222.6708

CAS No. 1136-75-0

3-Quinolinecarboxylic acid, 1,2,3,4-tetrahydro-4-oxo-, methyl ester

Catalog No.:AG000947 MDL No.:

MF:C11H11NO3 MW:205.2099

CAS No. 1136-76-1

1H-Pyrazole-5-carboxylic acid, 3-methyl-1-phenyl-

Catalog No.:AG000946 MDL No.:MFCD01693509

MF:C11H10N2O2 MW:202.2093

CAS No. 1136-77-2

Dibenzofuran, 4,6-dimethyl-

Catalog No.:AG000945 MDL No.:

MF:C14H12O MW:196.2445

CAS No. 1136-84-1

1-Naphthalenol, 5,6,7,8-tetrahydro-, 1-(N-methylcarbamate)

Catalog No.:AG000944 MDL No.:

MF:C12H15NO2 MW:205.2530

CAS No. 1136-86-3

Ethanone, 1-(3,4,5-trimethoxyphenyl)-

Catalog No.:AG000943 MDL No.:MFCD00008738

MF:C11H14O4 MW:210.2265

CAS No. 1136-87-4

1H-Indole-3-propanoic acid, 2-methyl-

Catalog No.:AG000942 MDL No.:

MF:C12H13NO2 MW:203.2371

CAS No. 1136-89-6

1-Naphthalenol, 1-(dihydrogen phosphate)

Catalog No.:AG000941 MDL No.:MFCD00003921

MF: MW:

CAS No. 113600-07-0

2,4-Diazabicyclo[4.2.0]octane-3,5-dione, 6-fluoro-8,8-dimethoxy-

Catalog No.:AG000940 MDL No.:

MF:C8H11FN2O4 MW:218.1823

CAS No. 113600-15-0

Benzo[k]fluoranthene, 9-fluoro-

Catalog No.:AG00093Z MDL No.:

MF:C20H11F MW:270.2997

CAS No. 113600-21-8

Indeno[1,2,3-cd]pyrene, 2-fluoro-

Catalog No.:AG00093Y MDL No.:

MF:C22H11F MW:294.3211

CAS No. 113600-24-1

Indeno[1,2,3-cd]pyrene, 8,9-difluoro-

Catalog No.:AG00093X MDL No.:

MF:C22H10F2 MW:312.3116

CAS No. 113600-56-9

Isobenzofuran, 1,3-dihydro-1-(1-naphthalenylmethylene)-

Catalog No.:AG00093W MDL No.:

MF:C19H14O MW:258.3139

CAS No. 113602-42-9

Potassium, (tribromostannyl)-, monohydrate (9CI)

Catalog No.:AG00093V MDL No.:

MF:Br3H2KOSn MW:415.5266

CAS No. 113602-62-3

Methyl 3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate

Catalog No.:AG00093U MDL No.:MFCD12924083

MF:C7H9NO3 MW:155.1513

CAS No. 113603-08-0

2-Naphthalenecarboxylic acid, dodecyl ester

Catalog No.:AG00093T MDL No.:

MF:C23H32O2 MW:340.4990

CAS No. 113603-09-1

2-Naphthalenecarboxylic acid, hexadecyl ester

Catalog No.:AG00093S MDL No.:

MF:C27H40O2 MW:396.6053

CAS No. 113603-97-7

1H-Isoindole-1,3(2H)-dione, 2-(2-chlorobenzoyl)-

Catalog No.:AG00093R MDL No.:

MF:C15H8ClNO3 MW:285.6819

CAS No. 113604-07-2

Acetamide, 2-cyano-N-(2,5-dimethoxyphenyl)-

Catalog No.:AG00093Q MDL No.:MFCD03382982

MF:C11H12N2O3 MW:220.2246

CAS No. 113604-56-1

Diaziridine, 1,2,3-trimethyl-

Catalog No.:AG000952 MDL No.:

MF:C4H10N2 MW:86.1356

CAS No. 113604-61-8

2,6-Piperidinedione, 3-(4-chlorophenyl)-4-phenyl-

Catalog No.:AG000951 MDL No.:

MF:C17H14ClNO2 MW:299.7516

CAS No. 113604-66-3

1H-Indole-2,4-dione, 3,5,6,7-tetrahydro-1-phenyl-

Catalog No.:AG000950 MDL No.:

MF:C14H13NO2 MW:227.2585

CAS No. 113604-75-4

1H-Indole-2,4-dione, 3,5,6,7-tetrahydro-6,6-dimethyl-1-phenyl-

Catalog No.:AG00094Z MDL No.:

MF:C16H17NO2 MW:255.3117

CAS No. 113606-74-9

1H-Indole, 1-methyl-3-(1-methylethyl)-2-(2-methylpropyl)-

Catalog No.:AG00094Y MDL No.:

MF:C16H23N MW:229.3605

CAS No. 113607-59-3

1,2,3-Thiadiazole-4-carboxylic acid, 7-bromo-5-nitro-8-quinolinyl ester

Catalog No.:AG00094X MDL No.:

MF:C12H5BrN4O4S MW:381.1615

CAS No. 113608-76-7

1H-Benzimidazole, 6-methyl-2-(5-nitro-2-furanyl)-

Catalog No.:AG00094W MDL No.:

MF:C12H9N3O3 MW:243.2182

CAS No. 113611-42-0

Piperidine, 4-methyl-4-propyl-

Catalog No.:AG00094V MDL No.:

MF:C9H19N MW:141.2539

CAS No. 113611-44-2

L-Serine, N-(1-oxo-2-propen-1-yl)-

Catalog No.:AG00094U MDL No.:

MF:C6H9NO4 MW:159.1400

CAS No. 113611-45-3

1,4-Heptanediol, (R)- (9CI)

Catalog No.:AG00094T MDL No.:

MF:C7H16O2 MW:132.2007

CAS No. 113611-58-8

1,4-Naphthalenedione, 2,8-bis(butylamino)-5-hydroxy-

Catalog No.:AG00094S MDL No.:

MF:C18H24N2O3 MW:316.3948

CAS No. 113611-68-0

L-Phenylalaninamide, L-threonyl-L-asparaginyl-L-arginyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-arginyl-

Catalog No.:AG00094R MDL No.:

MF:C48H75N17O11 MW:1066.2164

CAS No. 113611-75-9

Quinolinium, 2-[[2-[dimethyl[3-(triethylsilyl)propyl]ammonio]ethoxy]carbonyl]-1-methyl-, iodide (1:2)

Catalog No.:AG00094Q MDL No.:

MF:C24H40I2N2O2Si MW:670.4810

CAS No. 113611-82-8

Lithium, [3-[(dimethylamino)methylene]-1,4-cyclopentadien-1-yl]- (9CI)

Catalog No.:AG00094P MDL No.:

MF:C8H10LiN MW:127.1127

CAS No. 113611-86-2

3,6-Heptadien-2-ol, 2-methyl-3-(triethylsilyl)-, (E)- (9CI)

Catalog No.:AG00094O MDL No.:

MF:C14H28OSi MW:240.4570

CAS No. 113612-26-3

Benzenemethanaminium, N,N-dimethyl-N-octyl-, iodide (1:1)

Catalog No.:AG00094N MDL No.:

MF:C17H30IN MW:375.3313

CAS No. 113612-30-9

1-Butene, 1,2,3,3,4,4,4-heptafluoro-1-iodo-, (1Z)-

Catalog No.:AG00094M MDL No.:MFCD00155830

MF:C4F7I MW:307.9361

CAS No. 113612-56-9

Phosphonic acid, (2,3-dihydroxypropyl)-, bis(1-methylethyl) ester (9CI)

Catalog No.:AG00094L MDL No.:

MF:C9H21O5P MW:240.2338

CAS No. 113612-74-1

Indium, bromobis[(trimethylsilyl)methyl]-

Catalog No.:AG00094K MDL No.:

MF:C8H22BrInSi2 MW:369.1533

CAS No. 113612-76-3

Silane, [(fluorodimethylstannyl)methylidyne]tris[dimethylphenyl- (9CI)

Catalog No.:AG00094J MDL No.:

MF:C27H39FSi3Sn MW:585.5545

CAS No. 113612-78-5

1,4-Disilabenzene, 1,2,3,4,5,6-hexamethyl-

Catalog No.:AG00094I MDL No.:

MF:C10H18Si2 MW:194.4209

CAS No. 113612-84-3

Phosphine, (cyclobutylmethyl)bis(1,1-dimethylethyl)-, hydrobromide (1:1)

Catalog No.:AG00094H MDL No.:

MF:C13H28BrP MW:295.2392

CAS No. 113612-85-4

Phosphine, (2-cyclopropylethyl)bis(1,1-dimethylethyl)-, hydrobromide (1:1)

Catalog No.:AG00094G MDL No.:

MF:C13H28BrP MW:295.2392

CAS No. 113612-87-6

1H-1,2-Azaborole, 2,5-dihydro-

Catalog No.:AG00094F MDL No.:

MF:C3H6BN MW:66.8974

CAS No. 113613-16-4

Phosphorin, 2-(4-methylphenyl)-4,5-diphenyl-

Catalog No.:AG00094E MDL No.:

MF:C24H19P MW:338.3814

CAS No. 113613-27-7

Phosphinic acid, bis[4-(dimethylamino)-2-methylphenyl]- (9CI)

Catalog No.:AG00095R MDL No.:

MF:C18H25N2O2P MW:332.3771

CAS No. 113613-33-5

2H-Oxirenium, 2,2,3-trimethyl- (9CI)

Catalog No.:AG00095Q MDL No.:

MF:C5H9O+ MW:85.1244

CAS No. 113613-40-4

1H-Indole, 3-methyl-2-(3-nitrophenyl)-

Catalog No.:AG00095P MDL No.:

MF:C15H12N2O2 MW:252.2680

CAS No. 113613-44-8

9H-Fluoren-9-amine, 9-bromo-N-(diphenylmethylene)-

Catalog No.:AG00095O MDL No.:

MF:C26H18BrN MW:424.3318

CAS No. 113613-52-8

L-Phenylalanine, N-(4-thiazolidinylcarbonyl)-, (R)- (9CI)

Catalog No.:AG00095N MDL No.:

MF:C13H16N2O3S MW:280.3427

CAS No. 113613-63-1

Benzene, 1-bromo-2-(dibutoxymethyl)-

Catalog No.:AG00095M MDL No.:

MF:C15H23BrO2 MW:315.2459

CAS No. 113613-68-6

2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-nitro-, 4-hydrazone

Catalog No.:AG00095L MDL No.:

MF:C6H9N5O4 MW:215.1668

CAS No. 113613-75-5

1H-Purine-2,6-dione, 3,9-dihydro-1-methyl-9-[(phenylmethylene)amino]-

Catalog No.:AG00095K MDL No.:

MF:C13H11N5O2 MW:269.2587

CAS No. 113613-80-2

4-Cyclopentene-1,3-dione, 2-(2,5-dioxo-3-cyclopenten-1-ylidene)- (9CI)

Catalog No.:AG00095J MDL No.:

MF:C10H4O4 MW:188.1364

CAS No. 113613-99-3

Piperazinium, 1-ethenyl-1-[2-(1-piperazinyl)ethyl]-, chloride (1:1)

Catalog No.:AG00095I MDL No.:

MF:C12H25ClN4 MW:260.8067

CAS No. 113614-00-9

Pyridinium, 2,4-dimethyl-5-nitro-1-(2-oxo-2-phenylethyl)-, bromide (1:1)

Catalog No.:AG00095H MDL No.:

MF:C15H15BrN2O3 MW:351.1952

CAS No. 113614-02-1

Indolizine, 7-methyl-6-nitro-2-phenyl-

Catalog No.:AG00095G MDL No.:

MF:C15H12N2O2 MW:252.2680

CAS No. 113614-06-5

3-Pyridinecarbonitrile, 2-(ethenyloxy)-4-(methoxymethyl)-6-methyl-

Catalog No.:AG00095F MDL No.:

MF:C11H12N2O2 MW:204.2252

CAS No. 113614-50-9

Isoxazolidine, 3,5-bis(4-chlorophenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-, (3R,5R)-rel-

Catalog No.:AG00095E MDL No.:

MF:C20H19Cl2N3O MW:388.2904

CAS No. 113614-54-3

Isoxazolidine, 3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-, cis- (9CI)

Catalog No.:AG00095D MDL No.:

MF:C20H18Cl3N3O MW:422.7354

CAS No. 113614-56-5

Isoxazolidine, 3-(4-chlorophenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-(4-methylphenyl)-, cis- (9CI)

Catalog No.:AG00095C MDL No.:

MF:C21H22ClN3O MW:367.8719

CAS No. 113614-67-8

Pentanoic acid, 4-methyl-2-[2-oxo-2-[(phenylmethoxy)amino]ethyl]-

Catalog No.:AG00095B MDL No.:

MF:C15H21NO4 MW:279.3315

CAS No. 113615-00-2

2-Propenoic acid, 2-methyl-, 3-methylpentyl ester

Catalog No.:AG00095A MDL No.:

MF:C10H18O2 MW:170.2487

CAS No. 113615-06-8

Hydrazinecarbothioamide, 2-(5,6-diphenyl-1,2,4-triazin-3-yl)-

Catalog No.:AG000959 MDL No.:

MF:C16H14N6S MW:322.3876

CAS No. 113615-75-1

2H-1-Benzopyran-3-carbonitrile, 4-hydrazinyl-2-oxo-

Catalog No.:AG000958 MDL No.:

MF:C10H7N3O2 MW:201.1815

CAS No. 113615-78-4

Benzene, 1-chloro-2-isocyanato-3-methoxy-

Catalog No.:AG000957 MDL No.:

MF:C8H6ClNO2 MW:183.5917

CAS No. 113616-00-5

Magnesium, chloro[(tetrahydro-5-methylene-2H-pyran-3-yl)methyl]-

Catalog No.:AG000956 MDL No.:

MF:C7H11ClMgO MW:170.9196

CAS No. 113616-51-6

1-Aza-2,5-disilacyclopentane, 1-(2-furanylmethyl)-2,2,5,5-tetramethyl-

Catalog No.:AG000955 MDL No.:

MF:C11H21NOSi2 MW:239.4615

CAS No. 113616-57-2

Hexanoic acid, 5-(acetyloxy)-2,6-dibromo-, methyl ester

Catalog No.:AG000954 MDL No.:

MF:C9H14Br2O4 MW:346.0131

CAS No. 113616-84-5

2H-Pyran, 3-(1,3-dioxolan-2-ylmethyl)tetrahydro-4-(2-propenyl)-, trans- (9CI)

Catalog No.:AG000953 MDL No.:

MF:C12H20O3 MW:212.2854

CAS No. 113616-92-5

3-Indolizinecarbonitrile, 7-benzoyl-

Catalog No.:AG00096G MDL No.:

MF:C16H10N2O MW:246.2634

CAS No. 113617-08-6

Barium iron tin oxide

Catalog No.:AG00096F MDL No.:

MF:BaFeOSn MW:327.8724

CAS No. 113617-54-2

Cyclohexene, 3-chloro-, (R)- (9CI)

Catalog No.:AG00096E MDL No.:

MF:C6H9Cl MW:116.5887

CAS No. 113617-63-3

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel-

Catalog No.:AG00096D MDL No.:MFCD00864858

MF:C19H20F3N3O3 MW:395.3756

CAS No. 113618-02-3

2-Penten-1-one, 1-(1H-indol-3-yl)-4-methyl-

Catalog No.:AG00096C MDL No.:

MF:C14H15NO MW:213.2750

CAS No. 113618-25-0

Hexanoic acid, 2-butyl-3,5-dioxo-, methyl ester

Catalog No.:AG00096B MDL No.:

MF:C11H18O4 MW:214.2582

CAS No. 113618-49-8

Benzo[c]thiophene, 1,3,4,5,6,7-hexahydro-1-methyl-, 2,2-dioxide

Catalog No.:AG00096A MDL No.:

MF:C9H14O2S MW:186.2713

CAS No. 113618-91-0

Propanedioic acid, 2-(2-acetyl-3-amino-2-buten-1-yl)-, 1,3-diethyl ester

Catalog No.:AG000969 MDL No.:

MF:C13H21NO5 MW:271.3095

CAS No. 113619-02-6

Propanedioic acid, 2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-, 1,3-diethyl ester

Catalog No.:AG000968 MDL No.:

MF:C13H20N2O4 MW:268.3089

CAS No. 113619-05-9

2-Buten-1-ol, 2-(tributylstannyl)-4-(trimethylsilyl)-

Catalog No.:AG000967 MDL No.:

MF:C19H42OSiSn MW:433.3227

CAS No. 113619-16-2

Propanoic acid, 2-[2-(diphenylphosphino)hydrazinylidene]-, methyl ester

Catalog No.:AG000966 MDL No.:

MF:C16H17N2O2P MW:300.2921

CAS No. 113619-25-3

2-Butenoic acid, 3-[2-(diphenylphosphinyl)diazenyl]-, methyl ester

Catalog No.:AG000965 MDL No.:

MF:C17H17N2O3P MW:328.3022

CAS No. 113619-28-6

2-Butenoic acid, 3-[2-(diethoxyphosphinyl)diazenyl]-, methyl ester

Catalog No.:AG000964 MDL No.:

MF:C9H17N2O5P MW:264.2154

CAS No. 113619-40-2

Stannane, (2-fluoro-4-methoxyphenyl)trimethyl-

Catalog No.:AG000963 MDL No.:

MF:C10H15FOSn MW:288.9249

CAS No. 113619-43-5

Phosphorodiamidic chloride, tetrakis(1-methylethyl)- (9CI)

Catalog No.:AG000962 MDL No.:

MF:C12H28ClN2OP MW:282.7903

CAS No. 113619-47-9

Pentanal, 5-(diphenylphosphino)-2-methyl-

Catalog No.:AG000961 MDL No.:

MF:C18H21OP MW:284.3325

CAS No. 113619-53-7

1-Propanol, 3-(diphenylphosphino)-2-methyl-

Catalog No.:AG000960 MDL No.:

MF:C16H19OP MW:258.2952

CAS No. 113619-59-3

Benzenamine, N-[(ethenyldimethylsilyl)methyl]-

Catalog No.:AG00095Z MDL No.:MFCD20667630

MF:C11H17NSi MW:191.3449

CAS No. 113623-77-1

Benzenamine, 5-chloro-2-(2-pyridinyl)-

Catalog No.:AG00095Y MDL No.:

MF:C11H9ClN2 MW:204.6556

CAS No. 113623-78-2

Benzenamine, 5-methoxy-2-(2-pyridinyl)-

Catalog No.:AG00095X MDL No.:

MF:C12H12N2O MW:200.2365

CAS No. 113623-99-7

Acetamide, 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-, mixt. with 6-chloro-N-ethyl-N'-(1-methylethyl)-1,3,5-triazine-2,4-diamine and 1-(dichloroacetyl)hexahydro-3,3,8a-trimethylpyrrolo[1,2-a]pyrimidin-6(2H)-one (9CI)

Catalog No.:AG00095W MDL No.:

MF: MW:

CAS No. 113626-30-5

L-Tryptophan, 5-(phenylmethoxy)-

Catalog No.:AG00095V MDL No.:

MF:C18H18N2O3 MW:310.3471

CAS No. 113626-76-9

Stigmast-4-ene-3,6-diol, (3β,6β)-

Catalog No.:AG00095U MDL No.:MFCD03424239

MF:C29H50O2 MW:430.7061

CAS No. 113627-72-8

4-Oxepincarboxaldehyde, 4,5-dihydro-

Catalog No.:AG00095T MDL No.:

MF:C7H8O2 MW:124.1372

© 2019 Angene International Limited. All rights Reserved.